INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS
Sign Up to like & getrecommendations! Published in 2022 at "Retina"
DOI: 10.1097/iae.0000000000003488
Abstract: This retrospective, comparative case series assesses the 10-year outcomes of intravitreal anti-VEGF injections with and without verteporfin photodynamic therapy for the treatment of choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome. Purpose: To assess the… read more here.
Keywords: ivi; ocular histoplasmosis; choroidal neovascularization; treatment ... See more keywords
Properties of Patient-Reported Outcome Measures in Recessive Stargardt Disease
Sign Up to like & getrecommendations! Published in 2022 at "Ophthalmologica"
DOI: 10.1159/000527093
Abstract: Introduction: The study aimed to explore the psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI VFQ) and Impact of Vision Impairment (IVI) profile in recessive Stargardt disease (STGD1). Methods: The NEI VFQ-25… read more here.
Keywords: stargardt disease; nei vfq; vfq ivi; recessive stargardt ... See more keywords
E-Iron: Rethinking the Way We Deliver Intravenous Iron. Report of a Pilot Telemedicine Initiative
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-143356
Abstract: Introduction Iron deficiency is common in the community, affecting upwards of a third of females in their childbearing years. The majority of patients with iron deficiency anemia (IDA) will be successfully managed with simple oral… read more here.
Keywords: hematology; infusion; iron; face ... See more keywords